Is Quince Therapeutics Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: QNCX) stock is to Strong Buy QNCX stock.
Out of 3 analysts, 3 (100%) are recommending QNCX as a Strong Buy, 0 (0%) are recommending QNCX as a Buy, 0 (0%) are recommending QNCX as a Hold, 0 (0%) are recommending QNCX as a Sell, and 0 (0%) are recommending QNCX as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year QNCX price target, the average QNCX price target is $9.67, with the highest QNCX stock price forecast at $12.00 and the lowest QNCX stock price forecast at $6.00.
On average, Wall Street analysts predict that Quince Therapeutics's share price could reach $9.67 by Nov 14, 2025. The average Quince Therapeutics stock price prediction forecasts a potential upside of 371.56% from the current QNCX share price of $2.05.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.